新增10种药物免征增值税

商报：厘务局发布第062-2025号备忘录通告，根据食品药物管理署建议，新增10种治疗重大疾病药物列入免征增值税清单。

癌症治疗药物

1. Tegafur + Gimeracil + Oteracil Potassium capsule (20 mg/5.8 mg/19.6 mg)

2. Tegafur + Gimeracil + Oteracil Potassium capsule (25 mg/7.25 mg/24.5 mg)

糖尿病治疗药物

3. Metformin Hydrochloride + Teneligliptin extended-release tablet (as hydrobromide hydrate) (1 g/20 mg)

4. Metformin Hydrochloride + Teneligliptin extended release tablet (as hydrobromide hydrate) (500 mg/20 mg)

高胆固醇治疗药物

5. Atorvastatin (as calcium) + Fenobribrate film-coated tablet (20 mg/160 mg)

高血压治疗药物

6. Metoprolol tartrate + Ivabradine film-coated tablet (as hydrochloride) (50 mg/5 mg)

7. Metoprolol tartrate + Ivabradine film-coated tablet (as hydrochloride) (25 mg/5 mg)

精神疾病治疗药物

8. Lamotrigine dispersible/chewable tablet (5 mg)

9. Lamotrigine oral dispersible tablet (25 mg)

10. Lamotrigine tablet (25 mg)

厘务局长尊·鲁马义(Jun Lumagui)表示：“此次扩大免税范围旨在降低患者治疗成本，提升关键药物可及性，此为厘务局优质纳税服务的一环。”